265. Mengwen Huang, Miaomiao Zhang, Hongbin Zhu, Xiaojiao Du*, Jun Wang*, Mucosal Vaccine Delivery: A Focus on the Breakthrough of Specific Barriers. Acta Pharmaceutica Sinica B, 2022, 12, 3456-3474.

264. Mengwen Huang#, Songrong Wang#, Senbiao Chen#, Jilong Wang, Congfei Xu, Jing Liu, Zhexiong Lian*, Xiaojiao Du*, Jun Wang*, Pegylated Liposomal Mitoxantrone Modulates Tumor Immune Landscape to Boost PD-L1 Blockade Therapy. Nano Today, 2022, 44, 101500.

263. Jia Shi#, Meng-Wen Huang#, Zi-Dong Lu, Xiao-Jiao Du, Song Shen, Cong-Fei Xu*, Jun Wang*, Delivery of mRNA for Regulating Functions of Immune Cells. Journal of Controlled Release, 2022, 345, 494-511.

262. Jing-Yang Zhang#, Fang-Man Chen#, Rong Liu, Jia-Qi Luo, Yong-Cong Huang, Na Shu, Sui-Juan Zheng, Dan Shao, Kam W. Leong*, Jin-Zhi Du*, Nanoparticle-enabled concurrent modulation of phagocytosis and repolarization of macrophages for enhanced cancer immunotherapy. Nano Today, 2022, 47, 101651.

261. Cheng-Zhi Huang#, Yue Zhou#, Qi-Song Tong#, Qi-Jia Duan, Qing Zhang, Jin-Zhi Du*, Xue-Qing Yao*, Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer. Biomaterials, 2022, 290, 121827.

260. Kewei Wang#, Xuan Xiao#, Ye Liu, Qingyu Zon, Yalan Tu, Youyong Yuan*, Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy. Biomaterials, 2022, 289, 121803.

259. Liang Zhao, Dongdong Li, Yuxi Zhang, Qiaoyi Huang, Zhenghai Zhang, Chaoran Chen, Cong-Fei Xu, Xiao Chu, Yu Zhang, and Xianzhu Yang*, HSP70-Promoter-Driven CRISPR/Cas9 System Activated by Reactive Oxygen Species for Multifaceted Anticancer Immune Response and Potentiated Immunotherapy. ACS Nano 2022, 16, 9, 13821-13833.

258. Yangyang Zhao, Yansong Dong, Shuhan Yang, Yalan Tu, Chengbo Wang, Jun Li, Youyong Yuan*, and Zhexiong Lian, Bioorthogonal Equipping CAR-T Cells with Hyaluronidase and Checkpoint Blocking Antibody for Enhanced Solid Tumor Immunotherapy. ACS Central Science, 2022, 8, 5, 603-614.

257. Yalan Tu#, Xuan Xiao#, Yansong Dong, Jisi Li, Ye Liu, Qingyu Zong, Youyong Yuan*, Cinnamaldehyde-based poly(thioacetal): A ROS-awakened self-amplifying degradable polymer for enhanced cancer immunotherapy. Biomaterials, 2022, 289, 121795.

256. Ziyang Cao, Dongdong Li, Liang Zhao, Mengting Liu, Pengyue Ma, Yingli Luo & Xianzhu Yang*, Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery. Nature Communications, 2022, 13, 2038.

255. Mingdong Liu, Liangqi Huang, Weinan Zhang, Xiaochuan Wang, Yuanyuan Geng, Yuhao Zhang, Li Wang, Wenbin Zhang, Yun-Jiao Zhang, Shiyan Xiao*, Yan Bao*, Menghua Xiong* & Jun Wang*. A transistor-like pH-sensitive nanodetergent for selective cancer therapy. Nature Nanotechnology, 2022, DOI: 10.1038/s41565-022-01085-5.

254. Maolin Jiang, Ye Liu, Yansong Dong, Kewei Wang, Youyong Yuan*. Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy. Biomaterials, 2022, 284, 121480.

253. Jielian Zhou, Kewei Wang, Maolin Jiang, Jisi Li, Youyong Yuan*. Tumor-Acidity and Bioorthogonal Chemistry-Mediated Construction and Deconstruction of Drug Depots for Ferroptosis under Normoxia and Hypoxia. Acta biomaterialia, 2022, 142, 253-263.

252. Jisi Li, Qingyu Zong, Ye Liu, Xuan Xiao, Jielian Zhou, Zhongyi Zhao and Youyong Yuan*. Self-catalyzed tumor ferroptosis based on ferrocene conjugated reactive oxygen species generation and a responsive polymer. Chemical Communications, 2022, 58, 3294-3297.

251. Jing Liu, Shasha He, Yingli Luo, Yue Zhang, Xiaojiao Du, Cheng Xu, Kanyi Pu,* and Jun Wang*. Tumor-Microenvironment-Activatable Polymer Nano-Immunomodulator for Precision Cancer Photoimmunotherapy. Advanced Materials, 2022, 34, 2106654.

250. Kewei Wang, Maolin Jiang, Jielian Zhou, Ye Liu, Qingyu Zong, and Youyong Yuan*. Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy. ACS Nano, 2022, 16, 1, 721-735.

265. Mengwen Huang, Miaomiao Zhang, Hongbin Zhu, Xiaojiao Du*, Jun Wang*, Mucosal Vaccine Delivery: A Focus on the Breakthrough of Specific Barriers. Acta Pharmaceutica Sinica B, 2022, 12, 3456-3474.

264. Mengwen Huang#, Songrong Wang#, Senbiao Chen#, Jilong Wang, Congfei Xu, Jing Liu, Zhexiong Lian*, Xiaojiao Du*, Jun Wang*, Pegylated Liposomal Mitoxantrone Modulates Tumor Immune Landscape to Boost PD-L1 Blockade Therapy. Nano Today, 2022, 44, 101500.

263. Jia Shi#, Meng-Wen Huang#, Zi-Dong Lu, Xiao-Jiao Du, Song Shen, Cong-Fei Xu*, Jun Wang*, Delivery of mRNA for Regulating Functions of Immune Cells. Journal of Controlled Release, 2022, 345, 494-511.

262. Jing-Yang Zhang#, Fang-Man Chen#, Rong Liu, Jia-Qi Luo, Yong-Cong Huang, Na Shu, Sui-Juan Zheng, Dan Shao, Kam W. Leong*, Jin-Zhi Du*, Nanoparticle-enabled concurrent modulation of phagocytosis and repolarization of macrophages for enhanced cancer immunotherapy. Nano Today, 2022, 47, 101651.

261. Cheng-Zhi Huang#, Yue Zhou#, Qi-Song Tong#, Qi-Jia Duan, Qing Zhang, Jin-Zhi Du*, Xue-Qing Yao*, Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer. Biomaterials, 2022, 290, 121827.

260. Kewei Wang#, Xuan Xiao#, Ye Liu, Qingyu Zon, Yalan Tu, Youyong Yuan*, Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy. Biomaterials, 2022, 289, 121803.

259. Liang Zhao, Dongdong Li, Yuxi Zhang, Qiaoyi Huang, Zhenghai Zhang, Chaoran Chen, Cong-Fei Xu, Xiao Chu, Yu Zhang, and Xianzhu Yang*, HSP70-Promoter-Driven CRISPR/Cas9 System Activated by Reactive Oxygen Species for Multifaceted Anticancer Immune Response and Potentiated Immunotherapy. ACS Nano 2022, 16, 9, 13821-13833.

258. Yangyang Zhao, Yansong Dong, Shuhan Yang, Yalan Tu, Chengbo Wang, Jun Li, Youyong Yuan*, and Zhexiong Lian, Bioorthogonal Equipping CAR-T Cells with Hyaluronidase and Checkpoint Blocking Antibody for Enhanced Solid Tumor Immunotherapy. ACS Central Science, 2022, 8, 5, 603-614.

257. Yalan Tu#, Xuan Xiao#, Yansong Dong, Jisi Li, Ye Liu, Qingyu Zong, Youyong Yuan*, Cinnamaldehyde-based poly(thioacetal): A ROS-awakened self-amplifying degradable polymer for enhanced cancer immunotherapy. Biomaterials, 2022, 289, 121795.

256. Ziyang Cao, Dongdong Li, Liang Zhao, Mengting Liu, Pengyue Ma, Yingli Luo & Xianzhu Yang*, Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery. Nature Communications, 2022, 13, 2038.

255. Mingdong Liu, Liangqi Huang, Weinan Zhang, Xiaochuan Wang, Yuanyuan Geng, Yuhao Zhang, Li Wang, Wenbin Zhang, Yun-Jiao Zhang, Shiyan Xiao*, Yan Bao*, Menghua Xiong* & Jun Wang*. A transistor-like pH-sensitive nanodetergent for selective cancer therapy. Nature Nanotechnology, 2022, DOI: 10.1038/s41565-022-01085-5.

254. Maolin Jiang, Ye Liu, Yansong Dong, Kewei Wang, Youyong Yuan*. Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy. Biomaterials, 2022, 284, 121480.

253. Jielian Zhou, Kewei Wang, Maolin Jiang, Jisi Li, Youyong Yuan*. Tumor-Acidity and Bioorthogonal Chemistry-Mediated Construction and Deconstruction of Drug Depots for Ferroptosis under Normoxia and Hypoxia. Acta biomaterialia, 2022, 142, 253-263.

252. Jisi Li, Qingyu Zong, Ye Liu, Xuan Xiao, Jielian Zhou, Zhongyi Zhao and Youyong Yuan*. Self-catalyzed tumor ferroptosis based on ferrocene conjugated reactive oxygen species generation and a responsive polymer. Chemical Communications, 2022, 58, 3294-3297.

251. Jing Liu, Shasha He, Yingli Luo, Yue Zhang, Xiaojiao Du, Cheng Xu, Kanyi Pu,* and Jun Wang*. Tumor-Microenvironment-Activatable Polymer Nano-Immunomodulator for Precision Cancer Photoimmunotherapy. Advanced Materials, 2022, 34, 2106654.

250. Kewei Wang, Maolin Jiang, Jielian Zhou, Ye Liu, Qingyu Zong, and Youyong Yuan*. Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy. ACS Nano, 2022, 16, 1, 721-735.